Jefferson Einstein Philadelphia Hospital Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 65
• Hematopoietic Stem Cell Transplantation 25
• Multiple Myeloma Research and Treatments 11
• Chronic Myeloid Leukemia Treatments 9
• Myeloproliferative Neoplasms: Diagnosis and Treatment 8
• Chronic Lymphocytic Leukemia Research 7
• Cancer Genomics and Diagnostics 6
• Cancer Immunotherapy and Biomarkers 6
• CAR-T cell therapy research 6
• Colorectal Cancer Treatments and Studies 6
• Cutaneous Melanoma Detection and Management 6
• Glycosylation and Glycoproteins Research 6

Most cited

1. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.

   Cancer cell · 2022 · 343 citations · Uma Borate

2. Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.

   Blood · 2023 · 120 citations · Uma Borate

3. Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 46 citations · Uma Borate

4. Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes.

   Blood · 2025 · 37 citations · Uma Borate

5. NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 113 citations · Uma Borate

6. A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.

   American journal of hematology · 2023 · 74 citations · Uma Borate